At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 20 enrolled
Drug / intervention
Stem cell transplantationprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Phase 1 Study of Autologous Bone Marrow Stem Cells Transplantation in Patients With Temporal Lobe Epilepsy
In Brief
A Phase 1 clinical trial evaluating Stem cell transplantation for Epilepsy. Completed, enrolled 20 participants across 1 site.
Detailed Summary
This research investigates the use of autologous bone marrow stem cells for the treatment of medically refractory temporal lobe epilepsy patients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpilepsy
CountriesBrazil
CollaboratorsHospital Sao Lucas da PUCRS, Instituto do Cerebro da PUCRS
Timeline
Phase 1CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2008
First PostedJun 2009
Primary CompletionNov 2011
Study CompletionMay 2012
TodayJul 2026
First PostedJun 9, 2009
Enrollment StartJul 1, 2008
Primary CompletionNov 1, 2011
Study CompletionMay 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 17.1 years ago
Interventions
Stem cell transplantationprocedure
Transplantations with autologous bone marrow mononuclear stem cells by selective posterior cerebral artery angiography